I'm an administrator who's read all of this stuff about overuse of antipsychotics on long-term care residents. I like and trust my director of nursing, medical director and clinical staff — to a degree, that is — but what can I do to REALLY know that we're not overusing this stuff, and would not be liable for some sort of adverse regulatory or court findings?
Leaders in long-term care facilities should take steps to ensure that residents with dementia are not unnecessarily put back on antipsychotic medications, according to officials who spoke on a call with providers Monday.
Doctors practicing in long-term care settings should hone certain skills identified by leading stakeholders in order to produce higher quality outcomes, according to a prominent physician association. The list of competencies for physicians in post-acute and long-term care medicine was released Monday by AMDA-Dedicated to Long-Term Care (formerly the American Medical Directors Association).
More long-term care facilities are earning top marks in national quality ratings, but providers may need increased focus on infection control, according to the American Health Care Association's 2013 Quality Report. Between 2011 and 2012, providers improved "in almost all the quality measures generally used," the report states.
Fewer residents with dementia are being prescribed antipsychotic medications, according to new figures heralded by the government and the nation's largest nursing home association.
Providers reveal strategies for reducing unneccessary antipsychotics use for residents with dementia, and meeting industry-wide medication reduction goals
Effective pain management in long-term care is hampered by residents' attitudes and caregivers' misinterpretation of behaviors, according to newly published research in the journal Nursing Older People.
The American Medical Directors Association has joined with ABIM Foundation's Choosing Wisely® campaign to promote discussions between healthcare providers and patients for what medical tests or procedures may be unnecessary.
Nursing homes have made strides toward reducing antipsychotic medication use among residents with dementia, according to new figures from the Centers for Medicare & Medicaid Services and the American Health Care Association/National Center for Assisted Living.
Haloperidol, a common antipsychotic, is no more effective than a placebo in treating delirium in critically ill patients, according to a new study.
A pharmacy company on track to serve more than 400 healthcare facilities has received a $100 million investment from Fillmore Capital Partners, which owns Golden Living.